(LGND) |
| 0 (0%) 01-14 04:04 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 210.27 |
| Resistance 1: | 197.14 |
| Pivot price: | 196.21 |
| Support 1: | 175.89 |
| Support 2: | 146.34 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 2.260 |
| Book Value | 48.340 |
| PEG Ratio | 0.00 |
| Gross Profit | 7.863 |
| Profit Margin (%) | 19.34 |
| Operating Margin (%) | 46.85 |
| Return on Assets (ttm) | 1.5 |
| Return on Equity (ttm) | 5.4 |
Company news
Tue, 13 Jan 2026
A Look At Ligand Pharmaceuticals (LGND) Valuation As Royalty Growth And Investment Plans Take Focus - simplywall.st
Tue, 13 Jan 2026
$LGND stock is down 10% today. Here's what we see in our data. - Quiver Quantitative
Mon, 12 Jan 2026
Ligand Pharmaceuticals (LGND) Is Up 7.6% After Raising Long-Term Royalty Growth Outlook - What's Changed - simplywall.st
Mon, 12 Jan 2026
Behavioral Patterns of LGND and Institutional Flows - Stock Traders Daily
Wed, 17 Dec 2025
Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - Yahoo Finance
Mon, 15 Dec 2025
LGND: 2025 Analyst Day - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
